The new findings raise the possibility that, in BAK1-competent tumor cells, pharmacological BCL-2- associated X (BAX, apoptosis regulator) inhibitors may accelerate MOM permeabilization-driven mtDNA release, inducing cGAS signaling prior to caspase-dependent cleavage and inactivation of cGAS [201]. Here, CGAS is linked to neoplasm.